1. Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis
    Lorenzo Nicolè et al, 2017, Oncotarget CrossRef
  2. Practical Application of Lineage-Specific Immunohistochemistry Markers: Transcription Factors (Sometimes) Behaving Badly
    Si Kei et al, 2020, Archives of Pathology & Laboratory Medicine CrossRef
  3. A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets
    Ting Ma et al, 2021, Archives of Biochemistry and Biophysics CrossRef
  4. The new advance of SALL4 in cancer: Function, regulation, and implication
    Fatma A. Abouelnazar et al, 2023, Journal of Clinical Laboratory Analysis CrossRef
  5. Diagnostic Value of SALL4 and OCT3/4 in Pediatric Testicular Tumors
    Ovidiu Bîcă et al, 2024, Diagnostics CrossRef
  6. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif–containing 21
    Junji Itou et al, 2018, Journal of Biological Chemistry CrossRef
  7. Molecular Diagnosis in Ovarian Carcinoma
    Shailendra Dwivedi et al, 2019, Molecular Diagnostics in Cancer Patients CrossRef
  8. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
    Mina Sharbatoghli et al, 2022, Journal of Ovarian Research CrossRef
  9. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
    Xin Nie et al, 2019, Cancer Medicine CrossRef
  10. Pluripotency Stemness and Cancer: More Questions than Answers
    Jiří Hatina et al, 2021, Cell Biology and Translational Medicine, Volume 15 CrossRef
  11. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas
    Alev Ok Atılgan et al, 2023, International Journal of Surgical Pathology CrossRef
  12. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
    Boshu Sun et al, 2022, International Journal of Molecular Sciences CrossRef
  13. Salt‐like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin‐specific protease 21 to stabilize Yin Yang 1
    Qing‐Dong Wang et al, 2023, Pathology International CrossRef
  14. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis
    Basavaraj Vastrad et al, 2024, Egyptian Journal of Medical Human Genetics CrossRef
  15. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway
    CHUNLI DA et al, 2016, Oncology Reports CrossRef
  16. Functional and clinical significance of SALL4 in breast cancer
    Ebubekir Dirican et al, 2016, Tumor Biology CrossRef

  17. Sal-Like Protein 4 Transcription Factor: A Significant Diagnostic Biomarker Involved in Childhood ALL Resistance and Relapse


    Farzaneh Ohadi et al, 2020, Cancer Management and Research CrossRef
  18. The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application
    Yosuke YAMADA et al, 2018, Proceedings of the Japan Academy, Series B CrossRef
  19. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway
    J Kim et al, 2017, Oncogene CrossRef
  20. La protein regulates protein expression by binding with the mRNAs of target genes and participates the pathological process of ovarian cancer
    Xuan Huang et al, 2022, Frontiers in Oncology CrossRef
  21. Higher expression of SALL4 predicts poor cancer prognosis: A meta-analysis
    Hongyu Shen et al, 2017, Cancer Biomarkers CrossRef
  22. Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience
    Ovidiu Bîcă et al, 2024, International Journal of Molecular Sciences CrossRef